WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX), a leading global provider of medical devices for critical care and surgery, announced the launch of the triple-lumen ARROW® PICC with Chlorag+ard® Technology. This completes the Company’s portfolio of PICCs with the unique and groundbreaking Chlorag+ard® Technology.
“With the completion of our ARROW® PICC with Chlorag+ard® Technology portfolio, Teleflex can now help provide the benefits of Chlorag+ard® Technology to all patients with PICCs, whether they require a single-, double-, or triple-lumen device,” said Jay White, President, Vascular Division of Teleflex. “Because ARROW® PICCs with Chlorag+ard® Technology are both antimicrobial and antithrombogenic, they provide an extra measure of protection against thrombosis, occlusion, intimal hyperplasia and infection. That is a crucial advantage at a time when many hospitals still struggle to minimize these potentially deadly and costly complications. Additionally, as house-wide reporting takes effect as part of the Affordable Care Act in 2015, Chlorag+ard® Technology’s proven ability to reduce PICC-related CLABSI will be important for hospitals to consider.”
Help employers find you! Check out all the jobs and post your resume.
